Spinal Tech

The North American bone grafts and substitutes market is set to reach $2.1 billion by 2023, according to a GlobalData report.

Dublin, Ireland-based Medtronic announced the pricing of $2 billion-worth of senior notes.

The market for reprocessed medical devices is expected to exceed $5 billion by 2023.

Maple Grove, Minn.-based CVRx President and CEO Namid Yared was named chairman of Washington, D.C.-based AdvaMed's board of directors.

Invibio launched PEEK-OPTIMA™ in 1999 as the world's first implantable PEEK polymer. The implant material is ideal for spinal surgery because PEEK is radiolucent and has a modulus of elasticity close to bone, reducing stress shielding.

Menlo Park, Calif.-based Asterias Biotherapeutics announced the sixth and final patient who was administered AST-OPC1 after complete paralysis has exhibited positive signs following the six month study.

Fibrosis, the creation of dense scar tissue, often occurs around implanted medical devices, which inhibits the devices from performing their intended duties.

Richard H. Bundschu, MD, of Bradenton, Fla.-based Coastal Orthopedics Sports Medicine & Pain Management, is a principal investigator for a spinal cord stimulator study.

Hartford (Conn.) HealthCare is the first healthcare system in Connecticut to utilize Caesarea, Israel-based Mazor Robotics' Mazor X for spine surgeries.

The global robotics market will likely reach $13 billion by 2023, based on a Research Nester report, according to I-Connect007.